Several studies have shown that smoking is a major cause of the lower life expectancy of men compared to women, but there has been no research to assess how far international differences in sex differences in life expectancy and changes in these differences can be accounted for by smoking. This paper gives quantitative estimates of the effects of smoking on sex differences in life expectancy at age 35 
T
A he widening sex differential in life expectancy has been one of the most striking features in the development of mortality in the Western world during the twentieth century.
1 ' 2 Although this trend has ended and was even reversed in several countries in the late 1970s or early 1980s, the difference is still at least 5 years in all developed countries. 3 " 5 Several authors have attempted to determine the underlying causes of the changes in the sex differences in life expectancy. The conclusion of many of these studies has been that smoking, through its effects on mortality from circulatory diseases, cancer and bronchitis, is largely responsible. Studies estimating the quantitative contribution of smoking to sex differences in mortality have used many different methods and a wide variety of assumptions. The age ranges included, the periods covered, the smoking statuses distinguished, the relative risks applied and the indices used have all varied considerably. Some authors have used Helsinki, Finland, tel. +358 9 19123893, fax +358 9 19123967 aggregate data sets, relating national figures on tobacco consumption or smoking prevalence to national death rates. 7 ' 9 ' 10 Measures of the impact of smoking on health include (standardized or age-specific) mortality rates, potential years of life lost and life expectancies at different ages. Most studies have concentrated on the effect of smoking on mortality in the USA and Canada. 6 . 8 >"- 16 Even where other countries have been involved, estimates of die contribution of smoking have often been based on relative mortality risks for different smoking status categories derived from US national data sets (American Cancer Society Cancer Prevention Studies I and II) 17 ' 18 and these have then been applied to country-specific data on smoking prevalences. Usually, the effects of smoking have been studied for 1 specific year, generally die period for which a national survey on smoking patterns was available in die country concerned. Given diese differences in die mediods employed and die data used, it is practically impossible to estimate die effect of smoking on die time trends of sex differences in mortality or life expectancy and to do this for more than 1 country. Ideally, such a comparative analysis would need to have standardized national data sets on die relative risks of smoking and smoking prevalence rates relating to longer periods of time. It is not very likely diat such data sets will become available at least in the near future. Recently, a new method has been proposed by Peto et a [ 22,23 f or estimating indirectly mortality attributable to smoking. With this method it is possible to carry out a comparative study of the time trends and country-specific effects of smoking on male-female differences in mortality and life expectancy. In this paper we apply the indirect method of estimating the effect of smoking on trends in male and female life expectancy and on sex differences in life expectancy for 4 periods during 1970-1989 . Five countnes were selected for this study: Denmark, Finland, The Netherlands, Norway and Sweden. All of these countries have a relatively high level of socioeconomic development. All have also undertaken epidemiological studies to measure the influence of smoking on mortality. Notwidistanding these and other common characteristics, the countries concerned show some interesting differences which make it useful to include them in a comparative study; their levels of male excess mortality and their smoking patterns deviate considerab l y . 3, 24, 25 The method presented by Peto et al. • is relatively new and doubts have been voiced about its validity.
26~29 In this study we will therefore be attempting to assess die validity of the method by companng relevant parts of our results widi diose obtained in 8 national follow-up studies on smoking and mortality.
DATA AND METHODS
The indirect mediod used by Peto et al. 22 ' 23 and described in more detail by Lopez 30 takes die numbers of deadis from various causes of deadi by age and sex for a particular country and year and attributes certain proportions of them to tobacco. The data on deadis and die mean populations for the countries included in diis study were obtained from die standardized computer-tape transcripts of die WHO mortality data bank. 5 The WHO data are drawn from civil registration systems in each country. They include die annual numbers of deadis by cause of deadi, sex and 5 year age group as well as die relevant mean populations. The annual data were aggregated into 4 periods: 1970-1974, 1975-1979, 1980-1984 and 1985-1989 . The causes of dearh were classified into 9 major categories following die classification used by Peto et al. 22 ' 23 The groups and their ICD 8di revision codes are die following: lung cancer (162), upper aerodigestive cancer (moudi, pharynx, larynx or oesophagus 14O-150,161), other cancers (151-160, 163-209) , chronic obstructive pulmonary disease (490-493), odier respiratory diseases , vascular disease (390-459), cirrhosis (571), odier medical causes (rest of 000-799) and non-medical causes (800-999). The Peto-Lopez (P-L) mediod makes use of die results of die American Cancer Society's (ACS) second Cancer Prevention Study (CPS-II) on smoking and deadi among more riian 1,000,000 Americans aged 30 years or over at the start of the study in 1982.
18
" 31 These results include die deadi rates for selected causes of deadi by age and sex among never smokers and current cigarette smokers. In estimating deadis attributable to smoking using die P-L mediod, it is first assumed diat no deadis from liver cirrhosis and from non-medical causes are attributable to smoking. In addition, no deadis under age 35 years from any cause are counted as attributable to smoking. The deadis from lung cancer attributable to smoking are estimated by using for each age-sex group the lung cancer deadi rates among never smokers in die ACS study as an estimate of mortality from lung cancer not caused by smoking. The age-sex-specific differences between the observed national lung cancer rates and die ACS neversmoker lung cancer rates are used to estimate mortality from lung cancer attributable to smoking for age-sex groups in each country and period. The estimates of deadis attributable to smoking for die remaining causes of deadi are based on die assumption diat die lung cancer deadi rate in a given age-sex group in a given country and period reflects die entire smoking history of diat group in terms of prevalence, duration and intensity. For example, if die lung cancer mortality in an age-sex group is close to die lung cancer mortality for never smokers in die same age-sex group in die ACS study, it is assumed diat the past and current prevalence of smoking in diis group is small, and consequently only a small proportion of deadis from diseases odier dian lung cancer are attributed to smoking. The estimates of die deadis attributable to smoking for each age-sex group and cause of deadi category are calculated using die formulas given in Lopez. 30 The disease-specific ratios of the mortality of current smokers to that of never smokers used in calculating die estimates are based on die ACS study.
It can be expected diat diese mortality ratios are increased by confounding factors (e.g. healdi consciousness, alcohol use and poor diet). Peto et al. ' wanted to ensure that the risks of tobacco are not exaggerated and conservatively assumed diat only half of the excess mortality of current smokers from diseases odier rhan lung cancer observed in die ACS study is due to smoking. The estimates presented in this article are based on die same assumption.
The application of die P-L mediod results in estimates of the numbers of smoking-attributable deadis for each agesex group, country and period. When diese deadis are subtracted from die respective total numbers of deaths, estimates of deadis not attributable to smoking are obtained. On die basis of these deadis and die relevant mean populations, we calculated abridged life tables for the neversmoking male and female populations in each country and period. The 'never-smoking life expectancies' used in die presentation of the results are based on diese life tables. We have compared diem with die actual life expectancies calculated from the original age-sex-speciAc numbers of deaths. The agreement between these last calculations and die values of life expectancy published by die countries themselves was nearly perfect. The difference between the never-smoking life expectancy and the actual life expectancy in a given country and period is interpreted as the loss of life expectancy caused by smoking.
To facilitate evaluation of the validity of the results, we compared our results with those from 8 epidemiological follow-up studies on smoking and mortality in the countries concerned. For this purpose we calculated the proportions of smoking-attributable deaths of all deaths for those countries, periods and age groups that were covered by the follow-up studies.
RESULTS
Male and female life expectancy Figure 1 shows the development of male and female life expectancy at age 35 years and the estimated life expectancies of never smokers in the 5 countries from 1970-1974 to 1985-1989 . The estimated losses of life expectancy attributable to smoking are presented in figure 2 . During all 5 year periods, the loss of male life expectancy attributable to smoking was much greater in The Netherlands than in Sweden and Norway ( figure 2 ). The loss, on average, was almost 4 years in The Netherlands, but only 1.5 years in Norway and 1.2 years in Sweden. In The Netherlands and Sweden the loss remained more or less the same throughout die whole period and had almost no effect on changes in life expectancy. In Norway the loss attributable to smoking increased from 1.2 years to 1.7 years, which contributed to the slightly smaller rise of life expectancy than in The Netherlands and Sweden. The increase in life expectancy attributable to odier factors than smoking was approximately the same in all 3 countries (table I) .
The levels and trends in female life expectancy were also rather similar in The Netherlands, Norway and Sweden ( figure I) . From 1970 From -1974 From to 1984 From -1989 The development of male life expectancy was less favourable in Denmark than in the countries discussed above: life expectancy increased by only 0.5 years from 1970-1974 to 1985-1989 . This was partly due to the 0.4 year increase in die loss of life expectancy attributable to smoking and partly to the relatively small increase attributable to odier factors ( Table 2 summarizes the contribution of smoking to female-male differences in life expectancy at age 35 years. The unweighted average difference in life expectancy at age 35 years for all countries was 5.4 years in 1970-1974. More than 40% of diis difference was due to the higher smoking-attributable mortality of men. The average difference in life expectancy had increased by 0.5 years by [1985] [1986] [1987] [1988] [1989] . This was the result of 2 opposite changes. The sex difference attributable to smoking diminished due to die increase in smoking-attributable female mortality but the sex difference due to other factors increased more. As The female-male difference in life expectancy in Denmark was smaller than in the other countries both in 1970-1974 and 1985-1989 . This was partly due to the high female smoking-attributable loss of life expectancy and partly to the relatively small sex difference attributable to other factors. The changes in both of these components were almost exactly the same as the average changes in the countries studied (table 2) . Due to the low smoking-attributable loss of life expectancy of men, the contribution of smoking to the total sex difference was small in Sweden and Norway, only just over 20% in 1970-1974-The increase in the total sex difference was 0.7 years from 1970-1974 to 1985-1989 in bodi countries. This increase was due to the faster increase of female life expectancy not related to smoking. In 1985-1989 only 14% of the total sex difference in life expectancy in Sweden was attributable to smoking (table 2) .
Sex difference in life expectancy

Indirect estimates compared with direct estimates
To estimate the validity of the P-L method we have compared our results for the relevant age-sex groups and penods with estimates of the proportions of smokingattributable deadis calculated from 8 prospective epidemiological studies in the countries studied. Columns 1-3 in table 3 give some basic information about these studies. Column 4 gives the results on the percentage of smokers in each study and column 5 the ratio of the mortality of smokers to never smokers. These data were obtained directly from the reports and they are only crudely comparable. Column 6 gives the estimated proportion of deaths attributable to smoking for each of the cohorts. This estimate was presented by the original audiors in only one of the studies. For die other studies the proportions of smoking-attributable deaths have been estimated by using their results on the numbers of deadis from all causes and age-standardized deadi rates or risk ratios for the smoking categories and by applying the conventional formulas.' 8 The estimates are thus based on the assumption diat all the excess mortality of smokers -including excess mortality from accidents and violenceis due to smoking and confounding has no effect. Since the Danish study was carried out in an area in Copenhagen, where the prevalence of smoking was markedly higher than in the whole country, 33 the smokingattributable proportions of deaths given by die audiors have been adjusted accordingly. The estimates of proportions of smoking-attributable deadis presented in column 6 are crude for several reasons: most of the studies do not give age-specific data, some Table 2 Female-male difference (years) in life expectancy at age 35 years divided into difference attributable to smoking and not attributable to smoking, 1970-1974 and 1985-1989 Smoking and Ufe expectancy smoking categories (e.g. temporary smokers or mixed smokers) may have been omitted and there are variations in data collection techniques, response rates and classifications. Despite these problems the general order of magnitude of the estimates of smoking-attributable deaths should be reasonably correct, at least if the problem of possible confounding is not taken into account. Corresponding to each of the estimates of the proportion of smoking-attributable deaths based on national studies, we have calculated an indirect estimate for approximately die same age band and period using the P-L-method (column 7). For die periods before 1970 covered by die national studies, the estimates for 1970-1974 for die relevant age groups were used. Column 8 in table 3 gives the difference between die direct and indirect estimates. Figure 3 is a graphic presentation of this relationship. For almost all male cohorts and die Swedish female cohort 11 die direct and indirect estimates are very similar (absolute difference less dian 5% points). On die other Prospective epidemiological studies Years of follow-up (2) 1976-1989 1976-1989 ca 1969-1981 1959-1984 ca 1972-1982 1967-1978 1967-1978 1967-1978 ca 1975-1988 1963-1973 1963-1979 1976-1989 1976-1989 ca 1975-1988 1963-1973 Number of deaths hand, the indirect P-L estimates for male cohorts 5c and 6 (Norway) and female cohorts 9 (Denmark) and 10 (Norway) are lower than the direct estimates.
DISCUSSION
In order to provide country-specific estimates of the effects of smoking on male excess mortality it is necessary to have a material that is comparable over time, in which smoking prevalence and outcomes are measured for the same groups of the population and in which the same measure is used. For this purpose, the indirect estimates obtained by the Peto-Lopez procedure are valuable: they make it possible to estimate the effects of smoking even when no data are available on smoking prevalences. Before accepting the results as such, it is necessary to assess their validity. The comparisons above (table 3) indicate a relatively close correspondence between our results and those obtained in prospective national studies. This is surprising in view of the fact that both the indirect estimates and direct estimates of smoking-attributable deaths are necessarily crude. The results of epidemiological studies are always affected by random and systematic errors in measurement and by unrepresentativeness due to selective non-response or study design. It is impossible to estimate the net effects of these factors which vary from study to study. The fact that our estimates come close to those obtained in epidemiological studies does not necessarily imply that the results correctly show the excess mortality caused by smoking: that is, both sets of results may be biased. All excess mortality observed among smokers is not necessarily due to smoking, but it may be partly due to differences between smokers and non-smokers in other healthaffecting characteristics. The P-L method attempts to take this confounding effect into account: the estimated excess mortality of smokers in the 'mixture population' is halved before calculating the attributable mortality due to smoking for diseases other than lung cancer.
22
We calculated direct estimates for the proportions of smoking-attributable deaths presented in table 3 in the conventional way, assuming that all observed excess mortality among smokers was due to smoking. The halved excess mortality of smokers used in the indirect method should result in estimates of smoking-attributable deaths that are clearly lower than the estimates based on the unadjusted risk ratios, but this was the case only for 4 of the 13 cohorts included in 20 assume that all excess mortality in smokers is caused by smoking. The P-L procedure takes confounding into account in a J rather arbitrary but conservative way. As a result the risk ratios we used in calculating the indirect estimates are generally lower than the risk ratios obtained in the epidemiological studies listed in table 3. Despite the low risk ratios, the proportions of smoking-attributable deaths estimated by the indirect method are not systematically lower than those based on the observed risk ratios. The reason is that the percentages of smokers in the 'mixture populations' used in the P-L procedure and estimated on the basis of lung cancer mortality are usually higher than the actual percentages of smokers. For example, the percentage of smokers in the Finnish male cohort 3 was 65%, whereas the corresponding percentage of smokers in the 'mixture population' was 86%. These differences may be due to the CPS-II sample not being a representative one. The P-L method seems therefore not to be as conservative as was intended by Peto et al. 22 ' 23 In fact, the indirect estimates may exaggerate the causal effect of smoking almost to the same extent as conventional estimates, which do not take into account the effects of confounding. The results of this study are, therefore, more likely to overestimate than underestimate the effect of smoking on male excess mortality. It should be taken into account, however, that confounding factors have less impact on results on trends or differences than on results not involving comparisons of populations. To produce more accurate estimates of mortality attributable to smoking, more research should be done to find out to what extent the excess risk of smokers is due to confounding by sociodemographic factors, health-related lifestyles, psychological characteristics and other factors. The main contribution of this study is the tentative quantification of the effect of smoking on life expectancy and its contribution to trends in sex differences in 5 Northern European countries. Our results confirm the major influence of smoking on sex differences in life expectancy. On average more than 40% of the sex difference in 1970-1974 and more than 30% in 1985-1989 was accounted for by smoking in the 5 countries. For the USA in 1962, Retherford 6 estimated that of the total sex difference in life expectancy between ages 37 and 87 years (5.12 years), smoking accounted for 2.42 years (47%). In her thorough review of 12 studies, most of which were based on samples drawn from the US population from the late 1950s to 1980, Waldron 8 estimated that, over the adult age span, approximately half of the sex difference in total mortality was attributable to smoking. The average effect of smoking in the 5 countries studied here thus seems to have been about the same as in the USA in the 1970s. There were, however, marked differences between the countries. In particular, the contrast between the position of The Netherlands and that of Sweden and Norway is remarkable: whereas in these Scandinavian countries around 20% of the male excess mortality could be related to smoking in the 1970s, in The Netherlands more than 70% of the male excess mortality was related to tobacco consumption. [1970] [1971] [1972] [1973] [1974] -This is probably due to the early adoption of cigarette smoking in Finland: the per capita consumption of manufactured cigarettes was one of the highest in the world in the 1920s and 1930s and markedly higher than in the other countries studied here.'* However, the percentage of sex difference attributable to smoking was smaller in Finland than in The Netherlands because of the exceptionally high excess male mortality not attributable to smoking. As a result of the reduced smoking-attributable mortality among men, the sex difference in life expectancy diminished in Finland in the 1980s. In the other countries the difference continued to grow, although the loss of life expectancy caused by smoking among women increased. The widening of the sex difference in mortality caused by factors other than smoking more than compensated for the effects of the decrease in the sex difference in smoking-attributable mortality.
